Skip to main content
. 2018 May;18(2):132–140. doi: 10.17305/bjbms.2018.2519

FIGURE 2.

FIGURE 2

(A) A case with negative HER-2 amplification status, HER-2/CEP17 ratio <2, DAKO Paraffin Pretreatment Kit (4’,6-diamidino-2-phenylindole [DAPI] counterstain,×1000); (B) A case with positive HER-2 amplification status, HER-2/CEP17 > 2, DAKO Paraffin Pretreatment Kit (DAPI counterstain, ×1000); (C) Stromal cells (left half) were used as the internal control to tumor cells (right half), DAKO Paraffin Pretreatment Kit (DAPI counterstain, ×1000).